Kwick Forensic Solutions Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹370 Cr
- P/E
- 27.32
- ROE
- 39.08%
- PEG
- 0.29
- Price to sales
- 3.51
- Debt to equity
- 0.00
- 52W high / low
- ₹244 / ₹134
- Sales growth (5Y)
- 55.55%
- EBITDA margin
- 18.01%
- Net profit margin
- 12.81%
- Promoter holding
- 64.65%
- Sales (last year)
- ₹106 Cr
Incorporated in March 2005, Kwick Forensic Solutions Limited (formerly Kwick Soft Solutions Private Limited) is engaged in providing forensic science, evidence management, cyber and digital forensics, DNA forensics, and law-enforcement solutions across India.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Manufacturing
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Industrial Manufacturing companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹1,185 Cr | 109.0 | |
| 2 | 40%+ | Up 0–2% | ₹486 Cr | 29.9 | |
| 3 | 40%+ | Flat | ₹7,897 Cr | 92.3 | |
| 4 | 40%+ | Flat | ₹3,421 Cr | 74.4 | |
| 5 | 40%+ | Flat | ₹2,461 Cr | 58.4 | |
| 6 | 40%+ | Flat | ₹681 Cr | 40.0 |
Sign up free to see every company in the sector ranking and track Kwick Forensic.
Pro shows every company guiding 40%+ revenue growth →Full Industrial Manufacturing rankingFinancials of Kwick Forensic
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Kwick Forensic
Shareholding breakup across reporting periods.
| Sep 2026 | |
|---|---|
| Promoters + | 64.65% |
| FIIs + | 1.49% |
| DIIs + | 10.85% |
| Public + | 23.01% |
| No. of Shareholders | 896 |
Financials of Kwick Forensic
Quarterly Results
Quarter-by-quarter operating performance
| Sales + |
| Expenses + |
| Operating Profit |
| OPM % |
| Other Income + |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit + |
| EPS in Rs |
Financials of Kwick Forensic
Profit & Loss
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 12 | 4 | 20 | 30 | 65 | 106 |
| Expenses + | 10 | 4 | 17 | 25 | 53 | 87 |
| Operating Profit | 2 | 0 | 3 | 5 | 12 | 19 |
| OPM % | 15% | 9% | 16% | 18% | 19% | 18% |
| Other Income + | 0 | 0 | -0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 0 | 2 | 4 | 11 | 18 |
| Tax % | 30% | 7% | 25% | 25% | 24% | 26% |
| Net Profit + | 1 | 0 | 2 | 3 | 9 | 14 |
| EPS in Rs | 24.24 | 4.24 | 52.73 | 14.66 | 40.58 | 8.01 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Kwick Forensic
Balance Sheet
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.33 | 0.33 | 0.33 | 2 | 2 | 17 |
| Reserves | 2 | 2 | 4 | 8 | 26 | 25 |
| Borrowings + | 2 | 1 | 6 | 3 | 3 | 0 |
| Other Liabilities + | 2 | 2 | 3 | 6 | 16 | 19 |
| Total Liabilities | 6 | 6 | 13 | 19 | 47 | 61 |
| Fixed Assets + | 0 | 0 | 1 | 1 | 1 | 3 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 6 | 5 | 12 | 18 | 45 | 56 |
| Total Assets | 6 | 6 | 13 | 19 | 47 | 61 |
Financials of Kwick Forensic
Cash Flows
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 4 | -1 | 0 | -3 | 5 | 8 |
| Cash from Investing Activity + | -0 | 0 | -1 | -0 | -1 | -3 |
| Cash from Financing Activity + | -2 | -0 | 4 | -1 | 8 | -4 |
| Net Cash Flow | 2 | -1 | 4 | -4 | 12 | 1 |
| Free Cash Flow | 4 | -1 | -1 | -3 | 4 | 5 |
| CFO/OP | 217% | -356% | 14% | -37% | 46% | 55% |
Financials of Kwick Forensic
Ratios
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 45 | 34 | 32 | 144 | 111 | 79 |
| Inventory Days | 54 | 838 | 93 | 63 | 62 | 49 |
| Days Payable | 16 | 158 | 51 | 63 | 85 | 41 |
| Cash Conversion Cycle | 83 | 714 | 74 | 145 | 88 | 87 |
| Working Capital Days | 22 | 218 | -38 | 97 | 73 | 78 |
| ROCE % | 7% | 47% | 44% | 54% | 51% |
Continue your research
What Kwick Forensic's management said in earlier quarters
Others in Industrial Manufacturing this season
- Jyoti CNC Automation (Q2 FY27)
Revenue from Operations for Q2FY27: INR 602 Cr, up 18.5% YoY from INR 507.9 Cr in Q2FY26 (Page 12). Key investor presentation takeaways from Jyoti CNC Automatio
- Walchandnagar Industries (Q2 FY27)
5,178 lakhs for the same quarter in the previous year, representing a year-on-year increase of approximately 80.6%. Key results statement takeaways from Walchan
- EPack PrefabTech (Q2 FY27)
Revenue from Operations for Q2 FY 2026 (quarter ended September 30, 2026) is ₹50,112.53 lakhs (Consolidated) and ₹50,101.15 lakhs (Standalone). Key investor pre
- Indef Manufactur (Q2 FY27)
4,784.86 lakhs (~0.66% increase). Key results statement takeaways from Indef Manufacturing Ltd's Q2 FY27 results statement — and how it ranks against sector pee
